US 6319912
Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
expired A61KA61K31/425A61K31/535
Quick answer
US patent 6319912 (Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides) held by Ligand Pharmaceuticals Incorporated expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/425, A61K31/535, A61K31/56, A61K31/565